Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
19
MMI Quote, Financials, Valuation and Earnings
Last price:
$28.72
Seasonality move
:
6.26%
Day range:
$28.17 - $28.98
52-week range:
$27.61 - $42.80
Dividend yield:
1.74%
P/E ratio:
--
P/S ratio:
1.57x
P/B ratio:
1.82x
Volume:
295.9K
Avg. volume:
119.4K
1-year change:
-10.67%
Market cap:
$1.1B
Revenue:
$696.1M
EPS (TTM):
-$0.17
Analysts' Opinion
-
Consensus RatingMarcus & Millichap has received a consensus rating of Sell. The company's average rating is a Sell based on 0 Buy ratings, 0 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $30.00, Marcus & Millichap has an estimated upside of 4.13% from its current price of $28.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $30.00 representing 100% downside risk from its current price of $28.81.
Fair Value
-
According to the consensus of 1 analyst, Marcus & Millichap has 4.13% upside to fair value with a price target of $30.00 per share.
MMI vs. S&P 500
-
Over the past 5 trading days, Marcus & Millichap has overperformed the S&P 500 by 1% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Marcus & Millichap does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Marcus & Millichap has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Marcus & Millichap reported revenues of $145M.
Earnings Growth
-
Marcus & Millichap earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Marcus & Millichap reported earnings per share of -$0.11.
Enterprise value:
858.1M
EV / Invested capital:
1.39x
Price / LTM sales:
1.57x
EV / EBIT:
--
EV / Revenue:
1.21x
PEG ratio (5yr expected):
-0.52x
EV / Free cash flow:
65.16x
Price / Operating cash flow:
84.88x
Enterprise value / EBITDA:
186.47x
Gross Profit (TTM):
$269M
Return On Assets:
-0.82%
Net Income Margin (TTM):
-0.96%
Return On Equity:
-1.09%
Return On Invested Capital:
-1.09%
Operating Margin:
-12.21%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $620.2M | $712M | $129.1M | $145M | |
| Gross Profit | $387.5M | $232.2M | $269M | $52.2M | $56.7M | |
| Operating Income | $77.1M | -$63.4M | -$30.5M | -$20.1M | -$17.7M | |
| EBITDA | $99.5M | -$29M | $4.6M | -$11.1M | -$10.9M | |
| Diluted EPS | $1.62 | -$1.00 | -$0.17 | -$0.26 | -$0.11 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $382.2M | $570.8M | $405.2M | $343.5M | $325.1M | |
| Total Assets | $751.1M | $980.2M | $910.5M | $826.7M | $802M | |
| Current Liabilities | $91.3M | $192.3M | $102.9M | $92.6M | $86.2M | |
| Total Liabilities | $189.4M | $304.8M | $228.3M | $201.1M | $184.5M | |
| Total Equity | $561.7M | $675.4M | $682.2M | $625.6M | $617.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$20M | -$22.2M | $19.9M | -$51M | -$52.8M | |
| Cash From Investing | $56.4M | -$64.1M | $68.9M | -$21.6M | $57.2M | |
| Cash From Financing | -$123.6M | -$51.2M | -$29.3M | -$7.5M | -$8.1M | |
| Free Cash Flow | -$32.7M | -$31.4M | $13.2M | -$53.7M | -$54.3M | |
MMI
Sector
Market Cap
$1.1B
$1.1B
Price % of 52-Week High
67.31%
82.85%
Dividend Yield
1.74%
3.24%
Shareholder Yield
1.5%
4.07%
1-Year Price Total Return
-10.67%
--
Beta (5-Year)
1.225
0.756
Dividend yield:
1.74%
Annualized payout:
$0.50
Payout ratio:
-299.12%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$28.55
200-day SMA
Sell
Level
$36.57
Bollinger Bands (100)
Sell
Level
30.58 - 37.64
Chaikin Money Flow
Buy
Level
7.8M
20-day SMA
Sell
Level
$29.38
Relative Strength Index (RSI14)
Sell
Level
42.00
ADX Line
Sell
Level
25.95
Williams %R
Neutral
Level
-64.6018
50-day SMA
Sell
Level
$31.16
MACD (12, 26)
Sell
Level
-0.77
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
3.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.6076)
Buy
CA Score
(Annual)
Level (0.8402)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.1499)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.
Stock Forecast FAQ
In the current month, MMI has received 0 Buy ratings 0 Hold ratings, and 1 Sell ratings. The MMI average analyst price target in the past 3 months is $30.00.
-
Where Will Marcus & Millichap Stock Be In 1 Year?
According to analysts, the consensus estimate is that Marcus & Millichap share price will rise to $30.00 per share over the next 12 months.
-
What Do Analysts Say About Marcus & Millichap?
Analysts are divided on their view about Marcus & Millichap share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Marcus & Millichap is a Buy and believe this share price will drop from its current level to $30.00.
-
What Is Marcus & Millichap's Price Target?
The price target for Marcus & Millichap over the next 1-year time period is forecast to be $30.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MMI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Marcus & Millichap is a Sell. 1 of 1 analysts rates the stock a Sell at this time.
-
How Can I Buy Shares Of MMI?
You can purchase shares of Marcus & Millichap via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Marcus & Millichap shares.
-
What Is The Marcus & Millichap Share Price Today?
Marcus & Millichap was last trading at $28.72 per share. This represents the most recent stock quote for Marcus & Millichap. Yesterday, Marcus & Millichap closed at $28.81 per share.
-
How To Buy Marcus & Millichap Stock Online?
In order to purchase Marcus & Millichap stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for Jun 2
Regeneron Pharmaceuticals [REGN] is up 1.17% over the past day.
Buy
55
RGC alert for Jun 2
Regencell Bioscience Holdings [RGC] is down 12.77% over the past day.
Sell
42
AMBA alert for Jun 2
Ambarella [AMBA] is down 0.61% over the past day.
